Plunkett Research Online: Achieve Life Sciences Inc

ACHIEVE LIFE SCIENCES INC (ACHV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Achieve Life Sciences, Inc. is a specialty pharmaceutical company committed to the global development and commercialization of cytisinicline (also known as cytisine) for smoking cessation. Cytisinicline is an established 25-day smoking cessation treatment that has been approved and marketed in Cent.....



Achieve Life Sciences Inc
Ticker: ACHV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604-210-2217
Fax:
Address: 520 Pike Street
Suite 2250
Seattle, WA 98101 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Drugs-Cancer
Contacts Description

John Bencich CFO/Chief Accounting Officer/COO/Executive VP
Cindy Jacobs Chief Medical Officer/Executive VP
See More
Achieve Life Sciences, Inc. is a specialty pharmaceutical company committed to the global development and commercialization of cytisinicline (also known as cytisine) for smoking cessation. Cytisinicline is an established 25-day smoking cessation treatment that has been approved and marketed in Cent.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Dorsey & Whitney LLP
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Cytisinicline
Cytisine
Tabex
ORCA-1
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: